Topical a-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?

about

Topical a-Agonist Therapy for Persistent Facial Erythema of Rosacea and the Addition of Oxmetazoline to the Treatment Armamentarium: Where Are We Now?

Item

http://www.wikidata.org/entity/Q43379739

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Topical a-Agonist Therapy for ...... mamentarium: Where Are We Now?

@en

Topical a-Agonist Therapy for ...... mamentarium: Where Are We Now?

@nl

type

Item

label

Topical a-Agonist Therapy for ...... mamentarium: Where Are We Now?

@en

Topical a-Agonist Therapy for ...... mamentarium: Where Are We Now?

@nl

prefLabel

Topical a-Agonist Therapy for ...... mamentarium: Where Are We Now?

@en

Topical a-Agonist Therapy for ...... mamentarium: Where Are We Now?

@nl

P1476

Topical a-Agonist Therapy for ...... mamentarium: Where Are We Now?

@en

P2093

James Q Del Rosso

http://www.w3.org/2001/XMLSchema#string

P2860

Multidisciplinary Consideration of Potential Pathophysiologic Mechanisms of Paradoxical Erythema with Topical Brimonidine Therapy

Local thermal control of the human cutaneous circulation

Vascular adrenoceptors: an update.

Advances in understanding and managing rosacea: part 1: connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema

Neurovascular and neuroimmune aspects in the pathophysiology of rosacea.

Once-daily topical brimonidine tartrate gel 0·5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies.

Alpha 2-adrenoceptors and endothelium-derived relaxing factor.

Status report from the American Acne & Rosacea Society on medical management of acne in adult women, part 1: overview, clinical characteristics, and laboratory evaluation.

Optimizing the use of topical brimonidine in rosacea management: panel recommendations.

Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin.

P304

28-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29104721

http://www.w3.org/2001/XMLSchema#string

P932

5605221

http://www.w3.org/2001/XMLSchema#string